http://www.unboundmedicine.com/medline/ebm/research/ritonavirUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19924124/full_citation/Effect_of_Simultaneous_Induction_and_Inhibition_of_CYP3A_by_St_John's_Wort_and_Ritonavir_on_CYP3A_Activity_Hafner V, Jäger M, Matthée AK, et al. 
Effect of Simultaneous Induction and Inhibition of CYP3A by St John's Wort and Ritonavir on CYP3A Activity. [JOURNAL ARTICLE]
Clin Pharmacol Ther 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19923382/full_citation/Soybean_Isoflavonoid_Equol_Blocks_Ritonavir_Induced_Endothelial_Dysfunction_in_Porcine_Pulmonary_Arteries_and_Human_Pulmonary_Artery_Endothelial_Cells_Cheng C, Wang X, Weakley SM, et al. 
Soybean Isoflavonoid Equol Blocks Ritonavir-Induced Endothelial Dysfunction in Porcine Pulmonary Arteries and Human Pulmonary Artery Endothelial Cells. [JOURNAL ARTICLE]
J Nutr 2009 Nov 18.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19920914/full_citation/Raltegravir_in_the_management_of_HIV_infected_patients_Stellbrink HJ 
Raltegravir in the management of HIV-infected patients. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:281-288.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19919951/full_citation/Impact_of_reduced_dosing_of_lopinavir/ritonavir_in_virologically_controlled_HIV_infected_patients:_the_Kaledose_trial_Meynard JL, Morand-Joubert L, Lacombe K, et al. 
Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Nov 17.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19918106/full_citation/Avascular_osteonecrosis_of_the_femoral_head_in_three_West_African_HIV_infected_adults_with_heterozygous_sickle_cell_disease_Eholié SP, Ouiminga M, Ehui E, et al. 
Avascular osteonecrosis of the femoral head in three West African HIV-infected adults with heterozygous sickle cell disease. [Journal Article]
Antivir Ther 2009; 14(7):1011-4.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19918104/full_citation/Plasma_concentrations_of_generic_lopinavir/ritonavir_in_HIV_type_1_infected_individuals_van der Lugt J, Lange J, Avihingsanon A, et al. 
Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals. [Journal Article]
Antivir Ther 2009; 14(7):1001-4.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19906626/full_citation/Electrocardiogram_abnormalities_with_atazanavir_and_lopinavir/ritonavir_Rathbun CR, Liedtke MD, Blevins SM, et al. 
Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir. [Journal Article]
HIV Clin Trials 2009 Sep-Oct; 10(5):328-36.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19905037/full_citation/The_cost_effectiveness_of_home_based_provision_of_antiretroviral_therapy_in_rural_Uganda_Marseille E, Kahn JG, Pitter C, et al. 
The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. [Journal Article]
Appl Health Econ Health Policy 2009; 7(4):229-43.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19898246/full_citation/Insulin_Sensitivity_in_Multiple_Pathways_is_Differently_Affected_During_Zidovudine/Lamivudine_Containing_Compared_With_NRTI_Sparing_Combination_Antiretroviral_Therapy_van Vonderen MG, Blümer RM, Hassink EA, et al. 
Insulin Sensitivity in Multiple Pathways is Differently Affected During Zidovudine/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2009 Nov 4.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19897506/full_citation/Factors_influencing_lopinavir_and_atazanavir_plasma_concentration_Stöhr W, Back D, Dunn D, et al. 
Factors influencing lopinavir and atazanavir plasma concentration. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Nov 6.
Abstract | Full Citation